Not a member? Sign up for free!

Evolving Pharmacology Of Depression: Beyond The Monoamine Hypothesis

Archived Virtual Forum | October 9, 2018

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

According to the World Health Organization, major depressive disorder (MDD) currently impacts 300 million individuals worldwide and is the leading cause of disability globally. Current treatment strategies for depression are effective in one-third to half of those seeking treatment, leaving a large unmet need for new therapeutic options. Since the 1960’s, traditional pharmacological treatment strategies…

You must be logged in to read the full article: Join PsychU or Log In